$BKU

BankUnited, Inc.

1
1
1

No SEC Form 4 filings for $BKU in the last 30 days.

See all $BKU insider activity →
Low

Piper Sandler maintains Neutral rating on BankUnited, $44 price target

Piper Sandler kept a Neutral rating on BankUnited with a $44 price target, implying a 1.3% upside. The bank's recent financial results were weak, with balance sheet contraction and missed revenue targets, leading to lowered earnings estimates. However, potential loan growth in 2027 and expansion into high-growth markets may support future recovery, according to the analyst note.

BKU Maintained by Citigroup -- Price Target Lowered to $40.00

Citigroup maintained a 'Sell' rating on BankUnited (BKU) but lowered its price target to $40.00 from $42.00. GuruFocus values BKU at $43.00, slightly below its current price of $43.62, indicating a 1.4% overvaluation. The company has a GF Score of 79/100, with strengths in profitability and momentum but weaknesses in financial strength.

RBC Capital maintains Sector Perform rating on BankUnited, $48 price target

RBC Capital maintained a Sector Perform rating on BankUnited with a $48 price target, implying a 14.1% upside from the Oct 21 close of $42.08. The bank's management expects higher earnings and returns, driven by net interest income growth and margin expansion. Strong deposit growth potential supports the rating, according to RBC.

BKU sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 3 news stories mentioning BKU (BankUnited, Inc.). Coverage has been balanced: 1 bullish, 1 neutral, and 1 bearish.

Recent BKU coverage spans financial news, earnings and market movers.

What's driving BKU

AlphAI scores every news story that mentions BKU with an AI model for sentiment and relevance, and aggregates insider trades from BankUnited, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $BKU

Score

Piper Sandler maintains Neutral rating on BankUnited, $44 price target

Piper Sandler kept a Neutral rating on BankUnited with a $44 price target, implying a 1.3% upside. The bank's recent financial results were weak, with balance sheet contraction and missed revenue targets, leading to lowered earnings estimates. However, potential loan growth in 2027 and expansion into high-growth markets may support future recovery, according to the analyst note.

$BKUMed

BKU Maintained by Citigroup -- Price Target Lowered to $40.00

Citigroup maintained a 'Sell' rating on BankUnited (BKU) but lowered its price target to $40.00 from $42.00. GuruFocus values BKU at $43.00, slightly below its current price of $43.62, indicating a 1.4% overvaluation. The company has a GF Score of 79/100, with strengths in profitability and momentum but weaknesses in financial strength.

$BKUMed

Raymond James cuts BankUnited stock price target to $48 on revenue

Raymond James reduced its price target for BankUnited (BKU) to $48 from $49, citing lower revenue expectations due to mortgage rates and timing issues. The stock trades at $41.77, with a P/E ratio of 11.68. Despite the cut, the firm maintains an Outperform rating, noting potential balance sheet growth and share repurchases. BankUnited reported Q3 earnings of $1.03 per share, meeting expectations, with strong credit quality and capital levels.

$BKUMedAI 8/10

BankUnited, Inc. Reports 3Q 2026 Net Income of $72 million, $1.01 Diluted EPS; Excluding Impact of Securities Sales, Net Income of $74 million, $1.03 Diluted…

BankUnited, Inc. (BKU) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 BankUnited, Inc. Reports 3Q 2026 Net Income of $72 million, $1.01 Diluted EPS; Excluding Impact of Securities Sales, Net Income of $74 million, $1.03 Diluted EPS Continued Franchise Momentum Drives NIM Expansion, Stronger Funding Mix and Improved Credit Trends Miami

$GOLow

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Ally Financial, BankUnited, Ciena Corporation, CoreWeave, Dow, FormFactor, Lumentum Holdings, Moderna, Target, and More

Wall Street analysts issued upgrades, downgrades, and initiations for several companies. Notable upgrades include Target (TGT) to Buy at HSBC with a $190 target, and Grocery Outlet (GO) to Buy at Bank of America with a $15 target. Downgrades include Ally Financial (ALLY) to Equal Weight at Wells Fargo with a $42 target, and Moderna (MRNA) to Sell at Citigroup with an $80 target.

Related tickers